Condition
Fibrosis, Liver
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 13 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
13 shownChanges in Bile Acids and Microbiota in Patients With Hepatitis D Treated With BulvertideNCT07429864 · 2025-09-24
RECRUITINGGlobal Research Initiative for Patients Screening on MASHNCT05651724 · 2023-06-30
RECRUITINGThe European NAFLD RegistryNCT04442334 · 2015-05-01
RECRUITINGHIBOC = Hepatic Imaging Biomarkers in Obese ChildrenNCT06463223 · 2025-02-01
ENROLLING_BY_INVITATIONReducing Non-Alcoholic SteatohepatitisNCT06519448 · 2024-04-01
ENROLLING_BY_INVITATIONSemaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMNCT06005012 · 2023-07-25
ACTIVE_NOT_RECRUITINGPrevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNCT04595474 · 2021-01-14
ACTIVE_NOT_RECRUITINGEffects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 DiabetesNCT05473806 · 2020-09-18
UNKNOWNLiver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on MethotrexateNCT04493762 · 2020-08-13
UNKNOWNDIAbetes and NAFLDNCT06315361 · 2019-05-20
ACTIVE_NOT_RECRUITINGShear Wave ElastographyNCT04493346 · 2018-05-21
COMPLETEDLiver Fibrosis in Zambian HIV-HBV Co-infected PatientsNCT02344680 · 2015-10-01
COMPLETEDEvaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric SurgeryNCT03548597 · 2012-04-04
COMPLETEDCommon interventions
Anti-HIV AgentsDRUG1Empagliflozin 10 miligrams (mg)DRUG1Evaluation of the Diagnostic of Hepatic Fibrosis With the XL Probe of the Fibroscan Versus Biopsies in Severe Obese Patients Candidates to Bariatric SurgeryDEVICE1Evogliptin 5mgDRUG1Pioglitazone 15 Mg Oral TabletDRUG1PlaceboDRUG1SemaglutideDRUG1Transient ElastographyDEVICE1
Leading sponsors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2
Baylor Research Institute
1
European Georges Pompidou Hospital
1
Joslin Diabetes Center
1
Julius Clinical
1
Military University Hospital, Prague
1
Newcastle University
1
Sahlgrenska University Hospital
1
Seung Up Kim
1
The University of Hong Kong
1
University of Alabama at Birmingham
1
University of California, San Diego
1
Trial status mix
ACTIVE_NOT_RECRUITING3
COMPLETED3
RECRUITING3
ENROLLING_BY_INVITATION2
UNKNOWN2
Phase mix
NA1
PHASE21
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.